References:
1. Trevisi E, La Salvia A, Daniele L, Brizzi MP, De Rosa G, Scagliotti
GV, et al. Neuroendocrine breast carcinoma: a rare but challenging
entity. Medical Oncology. 2020;37(8):1-8.
2. Rosa M, Sheikh U, Nasir A. Breast Carcinomas with Neuroendocrine
Features (Neuroendocrine Carcinomas of the Breast). Neuroendocrine
Tumors: Review of Pathology, Molecular and Therapeutic Advances.
2016:179-201.
3. Tajima S, Horiuchi H. Neuroendocrine tumor, well-differentiated, of
the breast: a relatively high-grade case in the histological subtype.
Case reports in pathology. 2013;2013.
4. Miremadi A, Pinder S, Lee A, Bell J, Paish E, Wencyk P, et al.
Neuroendocrine differentiation and prognosis in breast adenocarcinoma.
Histopathology. 2002;40(3):215-22.
5. Jurčić P, Krušlin B, Gatalica Z, Sanati S, Vranić S. Breast carcinoma
with neuroendocrine features: a brief review. Endo Oncology and Metab.
2016;2:138-45.
6. Gündüz M, İşcan Y, Erbil Y, Müslümanoğlu M. NEUROENDOCRINE
DIFFERENTIATED BREAST CARCINOMA: A CASE REPORT. Meme Sagligi
Dergisi/Journal of Breast Health. 2009;5(4).
7. Tang F, Wei B, Tian Z, Gilcrease MZ, Huo L, Albarracin CT, et al.
Invasive mammary carcinoma with neuroendocrine differentiation:
histological features and diagnostic challenges. Histopathology.
2011;59(1):106-15.
8. Hejjane L, Oualla K, Bouchbika Z, Bourhafour M, Mimi AL, Boubacar E,
et al. Primary neuroendocrine tumors of the breast: two case reports and
review of the literature. Journal of medical case reports.
2020;14(1):1-6.
9. Singh G, Gupta P, Mathur S, Kataria S, Kumar S. Invasive mammary
carcinoma with neuroendocrine differentiation: a diagnostic challenge.
International J of Healthcare and Biomedical Research. 2014;2(3):42-6.
10. Perry KD, Reynolds C, Rosen DG, Edgerton ME, T Albarracin C,
Gilcrease MZ, et al. Metastatic neuroendocrine tumour in the breast: a
potential mimic of in‐situ and invasive mammary carcinoma.
Histopathology. 2011;59(4):619-30.
11. Irelli A, Sirufo MM, Morelli L, D’Ugo C, Ginaldi L, De Martinis M.
Neuroendocrine Cancer of the Breast: A Rare Entity. Journal of clinical
medicine. 2020;9(5):1452.
12. Zhang Y, Chen Z, Bao Y, Du Z, Li Q, Zhao Y, et al. Invasive
neuroendocrine carcinoma of the breast: a prognostic research of 107
Chinese patients. Neoplasma. 2013;60(2):215-22.
13. Tan PH, Schnitt SJ, van de Vijver MJ, Ellis IO, Lakhani SR.
Papillary and neuroendocrine breast lesions: the WHO stance.
Histopathology. 2015;66(6):761-70.
14. Adams R, Dyson P, Barthelmes L. Neuroendocrine breast tumours:
breast cancer or neuroendocrine cancer presenting in the breast? The
Breast. 2014;23(2):120-7.